In-Office Clinical Study of the Solo+ TTD
NCT: NCT05741333 · ACTIVE_NOT_RECRUITING
NCT IDNCT05741333
StatusACTIVE_NOT_RECRUITING
Start Date2023-03-30
Completion2028-03
Brief Summary
The objective of this study is to evaluate the safety and effectiveness of the Solo+ Tympanostomy Tube Device (Solo+ TTD) for the placement of tympanostomy tubes in paediatric patients undergoing a tympanostomy procedure.
Frequently Asked Questions
What is In-Office Clinical Study of the Solo+ TTD?
In-Office Clinical Study of the Solo+ TTD is a clinical trial registered under NCT05741333. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT05741333?
The current status of NCT05741333 (In-Office Clinical Study of the Solo+ TTD) is: ACTIVE_NOT_RECRUITING.
When did In-Office Clinical Study of the Solo+ TTD start?
In-Office Clinical Study of the Solo+ TTD started on 2023-03-30.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.